DSM Nutritional Products, based in Switzerland, today announced the formation of Nutritional Lipids that will combine Martek’s algal DHA Ω-3 and ARA Ω-6 products and DSM Nutritional Products’ polyunsaturated fatty acid (PUFAs) portfolio, making DSM the world’s leading innovator and supplier in this category. Nutritional Lipids will focus on developing and positioning innovative nutritional lipids products. The business will leverage Martek’s technology and market position in the U.S., and DSM Nutritional Products’ unique global asset footprint, marketing and sales, and premix network to capture significant global growth opportunities and accelerate international expansion.
In a large and growing body of scientific evidence nutritional lipids have shown significant health benefits and support brain, eye and cardiovascular health throughout life. Leading experts around the world have noted that healthy lipids such as DHA, EPA and ARA are important nutrients for health throughout the life cycle, yet many consumers do not include enough in their daily diets. The nutritional lipids category of health and nutrition ingredients is science-based, fast growing and in an early stage of development, with significant growth opportunities. Products from DSM's Nutritional Lipids portfolio can already be found in more than 400 brands of infant formula, nutritional supplements, functional foods and animal feeds sold worldwide.
Peter A. Nitze, who joined Martek in 2005 and held the position of COO at the time of the acquisition, will lead Nutritional Lipids as President and will be based in Columbia, Md. (United States). Steve Dubin, Martek’s CEO at the time of acquisition, will also be assuming a new role at DSM to be announced at a later date. David Abramson, Martek’s President at the time of acquisition, has been appointed Senior Executive Advisor for DSM Nutritional Products.
DSM Nutritional Products